Fort Knox personal page - To The Moon

Fort Knox

Fort Knox

No personal profile

40Follow

2Followers

2Topic

0Badge

11-05

$TMDX 20261113 90.0 CALL$

11-05

$INSP 20261120 60.0 PUT$ sleep medicine

11-04

$Ohmyhome Ltd(OMH)$ cannot open position today. Order denied. Only closing allowed. Why ah?

10-14

$CIG(06166)$ The optical connects market remain healthy as Datacenters installations continue weell into the 2031/2032. Substitutes? Hardly. Strong orders continue.. pressure to deliver escalates as ai models need to quickly update and maintain a lead. Dig in and shore up.

09-21

$TEM 20261002 65.0 PUT$

09-21

Hopefully can maintain

09-21

$APD 20261120 270.0 PUT$ Safe enough an option. They won a long term contract to Intel?

09-18

09-17

$CoreWeave, Inc.(CRWV)$

09-15

$BE 20261016 210.0 PUT$

09-15

$BE 20261016 210.0 PUT$

09-14

It's true this is ground breaking and will bring lasting advantage to Tempus. The market is amateur. Leave the valuation to the Experts!

Tempus AI Launches Initiative To Build A Million-Genome Dataset！

09-14

$CSOP SK Hynix Daily Max (2x) Leveraged Product(07709)$

09-05

$WXA.HK 20260929 172.50 PUT$ Biotech in China is in play.

09-01

$ALB.HK 20260929 127.50 CALL$ I'm loading alot Afraid I might become sunstantial shareholder of Alibabar soon. Have to call Joe Tsai for coffee sometime to scold him.

08-31

$TCH.HK 20261230 650.00 CALL$

08-28

I'm voting against it

C3.ai Announces Annual Shareholder Meeting

08-26

$ANA.HK 20260904 68.00 PUT$

08-26

$ANTA SPORTS(02020)$ bought this morning ard 72

08-24

How would Amer sports' performance affect Anta?

Earning Preview: ANTA SPORTS this quarter’s revenue is expected to increase by 8%, and institutional views are bullish

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4200118252877852","uuid":"4200118252877852","gmtCreate":1737017892413,"gmtModify":1769666581948,"name":"Fort Knox","pinyin":"fortknoxfortknox","introduction":"","introductionEn":null,"signature":"","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":40,"tweetSize":43,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.06.13","exceedPercentage":"93.90%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":1},{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.06.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.12.04","exceedPercentage":"93.53%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.11.20","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.01.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.06.13","exceedPercentage":"93.30%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":1},"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":25,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":625760056766624,"gmtCreate":1793809404872,"gmtModify":1793811980899,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/TMDX 20261113 90.0 CALL\">$TMDX 20261113 90.0 CALL$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/TMDX 20261113 90.0 CALL\">$TMDX 20261113 90.0 CALL$ </a>&nbsp;","text":"$TMDX 20261113 90.0 CALL$","images":[{"img":"https://community-static.tradeup.com/news/d5a9cc701ad80ed5d5b510717c82de50","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/625760056766624","isVote":1,"tweetType":1,"viewCount":176,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":625760137560576,"gmtCreate":1793809331592,"gmtModify":1793809334432,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/INSP 20261120 60.0 PUT\">$INSP 20261120 60.0 PUT$ </a> sleep medicine&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/INSP 20261120 60.0 PUT\">$INSP 20261120 60.0 PUT$ </a> sleep medicine&nbsp;","text":"$INSP 20261120 60.0 PUT$ sleep medicine","images":[{"img":"https://community-static.tradeup.com/news/7806c6d5d48db1a3fe4b1b734bc577cd","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/625760137560576","isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":625745644085592,"gmtCreate":1793805862316,"gmtModify":1793805865307,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/OMH\">$Ohmyhome Ltd(OMH)$ </a> cannot open position today. Order denied. Only closing allowed. Why ah?","listText":"<a href=\"https://ttm.financial/S/OMH\">$Ohmyhome Ltd(OMH)$ </a> cannot open position today. Order denied. Only closing allowed. Why ah?","text":"$Ohmyhome Ltd(OMH)$ cannot open position today. Order denied. Only closing allowed. Why ah?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/625745644085592","isVote":1,"tweetType":1,"viewCount":168,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":618409925431576,"gmtCreate":1791957975911,"gmtModify":1791959002984,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/06166\">$CIG(06166)$ </a> The optical connects market remain healthy as Datacenters installations continue weell into the 2031/2032.&nbsp; Substitutes? Hardly. Strong orders continue..&nbsp; pressure to deliver escalates as ai models need to quickly update and maintain a lead.&nbsp;&nbsp; Dig in and shore up.&nbsp;","listText":"<a href=\"https://ttm.financial/S/06166\">$CIG(06166)$ </a> The optical connects market remain healthy as Datacenters installations continue weell into the 2031/2032.&nbsp; Substitutes? Hardly. Strong orders continue..&nbsp; pressure to deliver escalates as ai models need to quickly update and maintain a lead.&nbsp;&nbsp; Dig in and shore up.&nbsp;","text":"$CIG(06166)$ The optical connects market remain healthy as Datacenters installations continue weell into the 2031/2032. Substitutes? Hardly. Strong orders continue.. pressure to deliver escalates as ai models need to quickly update and maintain a lead. Dig in and shore up.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/618409925431576","isVote":1,"tweetType":1,"viewCount":670,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":610207730844968,"gmtCreate":1790003197879,"gmtModify":1790003200114,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/TEM 20261002 65.0 PUT\">$TEM 20261002 65.0 PUT$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/TEM 20261002 65.0 PUT\">$TEM 20261002 65.0 PUT$ </a>&nbsp;","text":"$TEM 20261002 65.0 PUT$","images":[{"img":"https://community-static.tradeup.com/news/85e0f9316e2ba6f5ac261dd9e94c6e9b","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/610207730844968","isVote":1,"tweetType":1,"viewCount":883,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":610202207973824,"gmtCreate":1790001834945,"gmtModify":1790001838275,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"Hopefully can maintain","listText":"Hopefully can maintain","text":"Hopefully can maintain","images":[{"img":"https://community-static.tradeup.com/news/4a372a655a8b8dbf0e2bae30bde1d7c4","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/610202207973824","isVote":1,"tweetType":1,"viewCount":840,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":610196512870512,"gmtCreate":1789999968461,"gmtModify":1789999972105,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/APD 20261120 270.0 PUT\">$APD 20261120 270.0 PUT$ </a> Safe enough an option. They won a long term contract to Intel?","listText":"<a href=\"https://ttm.financial/OPT/APD 20261120 270.0 PUT\">$APD 20261120 270.0 PUT$ </a> Safe enough an option. They won a long term contract to Intel?","text":"$APD 20261120 270.0 PUT$ Safe enough an option. They won a long term contract to Intel?","images":[{"img":"https://community-static.tradeup.com/news/7089749c4e44a06e371fe4b648126dd7","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/610196512870512","isVote":1,"tweetType":1,"viewCount":882,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":609125004472584,"gmtCreate":1789738836995,"gmtModify":1789738839791,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/COO\">$Cooper(COO)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/COO\">$Cooper(COO)$ </a>&nbsp;","text":"$Cooper(COO)$","images":[{"img":"https://community-static.tradeup.com/news/6fa0cb770e2b76e53929015cb4598e36","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/609125004472584","isVote":1,"tweetType":1,"viewCount":974,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":608793678058680,"gmtCreate":1789657969220,"gmtModify":1789657971576,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/CRWV\">$CoreWeave, Inc.(CRWV)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/CRWV\">$CoreWeave, Inc.(CRWV)$ </a>&nbsp;","text":"$CoreWeave, Inc.(CRWV)$","images":[{"img":"https://community-static.tradeup.com/news/b36a68c2008c0ca4a6fb548a1896f9f9","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/608793678058680","isVote":1,"tweetType":1,"viewCount":1246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":608072616489480,"gmtCreate":1789483401666,"gmtModify":1789483403133,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/BE 20261016 210.0 PUT\">$BE 20261016 210.0 PUT$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/BE 20261016 210.0 PUT\">$BE 20261016 210.0 PUT$ </a>&nbsp;","text":"$BE 20261016 210.0 PUT$","images":[{"img":"https://community-static.tradeup.com/news/c76e70baf886ffeff0049da5f8236af1","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/608072616489480","isVote":1,"tweetType":1,"viewCount":1232,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":608128839308080,"gmtCreate":1789483366260,"gmtModify":1789483368502,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/BE 20261016 210.0 PUT\">$BE 20261016 210.0 PUT$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/BE 20261016 210.0 PUT\">$BE 20261016 210.0 PUT$ </a>&nbsp;","text":"$BE 20261016 210.0 PUT$","images":[{"img":"https://community-static.tradeup.com/news/cbec2a96a8a878a156d8b419b2d18208","width":"894","height":"1404"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/608128839308080","isVote":1,"tweetType":1,"viewCount":1161,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":607694143795472,"gmtCreate":1789391482288,"gmtModify":1789391485217,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"It's true this is ground breaking and will bring lasting advantage to Tempus. The market is amateur. Leave the valuation to the Experts!","listText":"It's true this is ground breaking and will bring lasting advantage to Tempus. The market is amateur. Leave the valuation to the Experts!","text":"It's true this is ground breaking and will bring lasting advantage to Tempus. The market is amateur. Leave the valuation to the Experts!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/607694143795472","repostId":"1120940844","repostType":2,"repost":{"id":"1120940844","kind":"video","weMediaInfo":{"introduction":"News Roundup: Tesla, NVIDIA & Other Bellwether Stocks","home_visible":1,"media_name":"Bellwether Stocks Movement","id":"1006566612","head_image":"https://community-static.tradeup.com/news/e78d47e84d6acfa800707e519dc4c88c"},"pubTimestamp":1789365816,"share":"https://ttm.financial/m/news/1120940844?lang=en_US&edition=fundamental","pubTime":"2026-09-14 14:03","market":"us","language":"en","title":"Tempus AI Launches Initiative To Build A Million-Genome Dataset！","url":"https://stock-news.laohu8.com/highlight/detail?id=1120940844","media":"Bellwether Stocks Movement","summary":"","content":"","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tempus AI Launches Initiative To Build A Million-Genome Dataset！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTempus AI Launches Initiative To Build A Million-Genome Dataset！\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1006566612\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/e78d47e84d6acfa800707e519dc4c88c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bellwether Stocks Movement </p>\n<p class=\"h-time\">2026-09-14 14:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/1465.webp","relate_stocks":{"TEM":"Tempus AI"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120940844","news_type":1,"symbols_score_info":{"TEM":2}},"isVote":1,"tweetType":1,"viewCount":1222,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":607727463601104,"gmtCreate":1789367645341,"gmtModify":1789367648268,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/07709\">$CSOP SK Hynix Daily Max (2x) Leveraged Product(07709)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/07709\">$CSOP SK Hynix Daily Max (2x) Leveraged Product(07709)$ </a>&nbsp;","text":"$CSOP SK Hynix Daily Max (2x) Leveraged Product(07709)$","images":[{"img":"https://community-static.tradeup.com/news/af9ee96599d04bb1db6124beee33b2c9","width":"894","height":"1470"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/607727463601104","isVote":1,"tweetType":1,"viewCount":1129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":604274580226816,"gmtCreate":1788564958577,"gmtModify":1788564961829,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/WXA.HK 20260929 172.50 PUT\">$WXA.HK 20260929 172.50 PUT$ </a> Biotech in China is in play.&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/WXA.HK 20260929 172.50 PUT\">$WXA.HK 20260929 172.50 PUT$ </a> Biotech in China is in play.&nbsp;","text":"$WXA.HK 20260929 172.50 PUT$ Biotech in China is in play.","images":[{"img":"https://community-static.tradeup.com/news/09f1c0b03929c3d77d5e20fd7f0a7837","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/604274580226816","isVote":1,"tweetType":1,"viewCount":912,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":602898092167784,"gmtCreate":1788228899955,"gmtModify":1788253126926,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/ALB.HK 20260929 127.50 CALL\">$ALB.HK 20260929 127.50 CALL$ </a> I'm loading alot&nbsp; Afraid I might become sunstantial shareholder of Alibabar soon. Have to call Joe Tsai for coffee sometime to scold him.&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/ALB.HK 20260929 127.50 CALL\">$ALB.HK 20260929 127.50 CALL$ </a> I'm loading alot&nbsp; Afraid I might become sunstantial shareholder of Alibabar soon. Have to call Joe Tsai for coffee sometime to scold him.&nbsp;","text":"$ALB.HK 20260929 127.50 CALL$ I'm loading alot Afraid I might become sunstantial shareholder of Alibabar soon. Have to call Joe Tsai for coffee sometime to scold him.","images":[{"img":"https://community-static.tradeup.com/news/a3af66f88471eacb5bd1546850530f49","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/602898092167784","isVote":1,"tweetType":1,"viewCount":1623,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":602745608745352,"gmtCreate":1788191748591,"gmtModify":1788192262117,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/TCH.HK 20261230 650.00 CALL\">$TCH.HK 20261230 650.00 CALL$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/TCH.HK 20261230 650.00 CALL\">$TCH.HK 20261230 650.00 CALL$ </a>&nbsp;","text":"$TCH.HK 20261230 650.00 CALL$","images":[{"img":"https://community-static.tradeup.com/news/1fbbb1f2dd7bc7f9e9192e43870140fc","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/602745608745352","isVote":1,"tweetType":1,"viewCount":1008,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":601651118387304,"gmtCreate":1787924545601,"gmtModify":1787924548444,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"I'm voting against it","listText":"I'm voting against it","text":"I'm voting against it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/601651118387304","repostId":"2662699190","repostType":2,"repost":{"id":"2662699190","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1787911519,"share":"https://ttm.financial/m/news/2662699190?lang=en_US&edition=fundamental","pubTime":"2026-08-28 18:05","market":"us","language":"en","title":"C3.ai Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2662699190","media":"Reuters","summary":"C3.ai announces annual shareholder meetingC3.ai will hold its annual shareholder meeting virtually on Oct. 26, 2026.Shareholders will vote on electing three Class III directors, including John C. Dwye","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/AI\">C3.ai</a> announces annual shareholder meeting\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          C3.ai will hold its annual shareholder meeting virtually on Oct. 26, 2026.\n        </li>\n<li>\n          Shareholders will vote on electing three Class III directors, including John C. Dwyer, Michael G. McCaffery, Stephen M. Ward, Jr.\n        </li>\n<li>\n          Advisory vote scheduled on executive compensation.\n        </li>\n<li>\n          Auditor ratification proposed for Deloitte &amp; Touche as independent accounting firm for the fiscal year ending April 30, 2027.\n        </li>\n<li>\n          Vote planned on amending and restating the 2020 Equity Incentive Plan, including a 10,000,000-share increase and evergreen extension to 2036.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C3.ai Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001577526-26-000110), on August 28, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C3.ai Announces Annual Shareholder Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC3.ai Announces Annual Shareholder Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-08-28 18:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/AI\">C3.ai</a> announces annual shareholder meeting\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          C3.ai will hold its annual shareholder meeting virtually on Oct. 26, 2026.\n        </li>\n<li>\n          Shareholders will vote on electing three Class III directors, including John C. Dwyer, Michael G. McCaffery, Stephen M. Ward, Jr.\n        </li>\n<li>\n          Advisory vote scheduled on executive compensation.\n        </li>\n<li>\n          Auditor ratification proposed for Deloitte &amp; Touche as independent accounting firm for the fiscal year ending April 30, 2027.\n        </li>\n<li>\n          Vote planned on amending and restating the 2020 Equity Incentive Plan, including a 10,000,000-share increase and evergreen extension to 2036.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C3.ai Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001577526-26-000110), on August 28, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4587":"ChatGPT概念","BK4543":"AI","BK4585":"ETF&股票定投概念","AIYY":"YIELDMAX AI OPTION INCOME STRATEGY ETF","BK4528":"SaaS概念","BK4588":"碎股","AI":"C3.ai, Inc.","BK4551":"寇图资本持仓","BK4023":"应用软件"},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLMN6kz:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2662699190","content_text":"<a href=\"https://laohu8.com/S/AI\">C3.ai</a> announces annual shareholder meeting\n    \n\n\n          C3.ai will hold its annual shareholder meeting virtually on Oct. 26, 2026.\n        \n\n          Shareholders will vote on electing three Class III directors, including John C. Dwyer, Michael G. McCaffery, Stephen M. Ward, Jr.\n        \n\n          Advisory vote scheduled on executive compensation.\n        \n\n          Auditor ratification proposed for Deloitte & Touche as independent accounting firm for the fiscal year ending April 30, 2027.\n        \n\n          Vote planned on amending and restating the 2020 Equity Incentive Plan, including a 10,000,000-share increase and evergreen extension to 2036.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C3.ai Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001577526-26-000110), on August 28, 2026, and is solely responsible for the information contained therein.","news_type":1,"symbols_score_info":{"AI":0.9,"AIYY":0.6}},"isVote":1,"tweetType":1,"viewCount":936,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":600838188621888,"gmtCreate":1787726102252,"gmtModify":1787728369106,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/ANA.HK 20260904 68.00 PUT\">$ANA.HK 20260904 68.00 PUT$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/ANA.HK 20260904 68.00 PUT\">$ANA.HK 20260904 68.00 PUT$ </a>&nbsp;","text":"$ANA.HK 20260904 68.00 PUT$","images":[{"img":"https://community-static.tradeup.com/news/7d9b94e0cec0dcabcdf183d4181cc806","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/600838188621888","isVote":1,"tweetType":1,"viewCount":1379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":600833691357288,"gmtCreate":1787724978455,"gmtModify":1787724981763,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/02020\">$ANTA SPORTS(02020)$ </a> bought this morning ard 72","listText":"<a href=\"https://ttm.financial/S/02020\">$ANTA SPORTS(02020)$ </a> bought this morning ard 72","text":"$ANTA SPORTS(02020)$ bought this morning ard 72","images":[{"img":"https://community-static.tradeup.com/news/f68c4436bebc9315fed978d975a8a99c","width":"894","height":"1373"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/600833691357288","isVote":1,"tweetType":1,"viewCount":943,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":600124302594616,"gmtCreate":1787554647253,"gmtModify":1787554650178,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4200118252877852","authorIdStr":"4200118252877852"},"themes":[],"title":"","htmlText":"How would Amer sports' performance affect Anta?","listText":"How would Amer sports' performance affect Anta?","text":"How would Amer sports' performance affect Anta?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/600124302594616","repostId":"1116654071","repostType":2,"repost":{"id":"1116654071","kind":"news","weMediaInfo":{"introduction":"Focus on earnings forecast and in-depth analysis","home_visible":1,"media_name":"Earnings Agent","id":"1025659746","head_image":"https://community-static.tradeup.com/news/decf3d8a922fc5c1c1d787bf8b36173f"},"pubTimestamp":1787104839,"share":"https://ttm.financial/m/news/1116654071?lang=en_US&edition=fundamental","pubTime":"2026-08-19 10:00","market":"hk","language":"en","title":"Earning Preview: ANTA SPORTS this quarter’s revenue is expected to increase by 8%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1116654071","media":"Earnings Agent","summary":"Abstract ANTA Sports Products Limited will report results on August 26, 2026 post-Market, with investors watching revenue growth momentum, margin resilience, and brand-mix execution amid a...","content":"<p><h2>Abstract</h2>\nANTA Sports Products Limited will report results on August 26, 2026 post-Market, with investors watching revenue growth momentum, margin resilience, and brand-mix execution amid a competitive Chinese sportswear landscape.\n<h2>Market Forecast</h2>\nBased on recent operating disclosures and sell-side channel checks, this quarter’s revenue is projected to rise by about 8% year over year in RMB terms, supported by low-single-digit growth for the ANTA and FILA brands and faster expansion in higher-end outdoor labels; gross profit margin is expected to remain around the 60% area and net margin around the mid-teens, while adjusted EPS isn’t currently guided. The main business is expected to highlight balanced growth across core brands, steady pricing, and healthy inventory with a continued tilt toward premium performance and outdoor categories. The most promising segment appears to be the high-end “All Other Brands” cluster, with revenue of 17.00 billion RMB in the most recently reported period and a prior year growth rate of 59.20%, with recent retail indicators suggesting 25–30% year-over-year expansion for the quarter in focus.\n<h2>Last Quarter Review</h2>\nGross profit margin was 60.73%, net profit margin was 15.73%, and GAAP net profit attributable to shareholders was 3.28 billion RMB; revenue and adjusted EPS were not disclosed at the quarterly level. A key highlight was the stable margin profile alongside disciplined discounting and inventory control observed in recent trading updates. Main-business highlights: ANTA Brand generated 34.75 billion RMB, FILA produced 28.47 billion RMB, and All Other Brands delivered 17.00 billion RMB in the most recently reported period; meanwhile, recent operational updates indicated low-single-digit retail sales growth for ANTA and FILA and 25–30% growth for the outdoor-focused All Other Brands cohort.\n<h2>Current Quarter Outlook</h2>\n<h3>Main Business: Execution Discipline and Margin Resilience</h3>\nThe key focus for this quarter is on maintaining the quality of revenue in the core ANTA and FILA businesses. Recent retail trends point to low-single-digit growth for both brands, with management and sell-side tracking emphasizing stable discounting and healthier channel inventories. That backdrop, combined with a product mix anchored in performance running, basketball and athleisure, is conducive to sustaining gross margin near 60% even if top-line growth skews toward single digits. Operational execution remains central: the brand teams are leaning into tighter SKU management, targeted replenishment, and more granular retail operations to protect sell-through and minimize markdown risk. The company’s pricing and promotional cadence will be closely watched in the quarter given weather-related traffic variability and intense industry competition; nevertheless, recent commentary indicates the ability to hold pricing where product innovation is clearly communicated and hero franchises are supported by consistent marketing.</p>\n<p><h3>Most Promising Business: Outdoor and Premium Brands</h3>\nThe outdoor and premium brand cluster (reflected within “All Other Brands”) continues to be the fastest-growing part of the portfolio. In the most recently reported period, this group delivered 17.00 billion RMB of revenue, and the previous year’s growth rate of 59.20% underscores a robust base of demand and effective brand positioning; recent quarter retail indicators of 25–30% year-over-year growth suggest that momentum is carrying through into this quarter’s readout. The drivers behind this trajectory include rising consumer interest in outdoor and performance apparel, improvements in store productivity, and a broadened product range covering mountaineering, trail running, and urban outdoor crossovers. This mix typically carries structurally higher gross margins than mass-market lines, which can provide an incremental lift to group profitability when the outdoor share nudges higher. The market will watch whether supply-chain coordination and allocation planning can keep hot-selling items in stock while avoiding a build-up of slow movers, as this directly influences full-price sell-through and gross margin realization in the quarter.</p>\n<p><h3>What May Matter Most for the Stock: Growth-Mix, Discounts, and Retail Traffic</h3>\nThis quarter, share-price reaction is likely to be most sensitive to the interplay of growth-mix and discount discipline. If outdoor and premium labels again post high-20s growth and the company keeps promotional intensity contained across ANTA and FILA, investors may reward the print for margin stability even without outsized revenue acceleration. Conversely, any sign of a traffic-induced step-up in discounts or an inventory back-up would raise questions about the durability of margins into the second half. Another swing factor is the cadence of brand leadership transitions and how seamlessly those teams deliver product refresh cycles; early indications from sell-side checks suggest management changes have been orderly and effects on execution limited. Finally, the market will parse commentary on channel health and e-commerce momentum, looking for confirmation that sell-out is tracking ahead of sell-in and that online growth is offsetting any weather or traffic variability offline. In short, the path of least resistance for the stock this quarter is tied to confirming steady margins, validating the outdoor-led growth mix, and sustaining low-single-digit gains in ANTA and FILA without sacrificing price integrity.</p>\n<p><h2>Analyst Opinions</h2>\nThe prevailing institutional stance is bullish, with cited houses uniformly positive over the period reviewed. DBS Group Research analysts Alison Fok and Mavis Hui reiterated a constructive view as their channel work showed ANTA and FILA delivering low-single-digit retail growth with All Other Brands expanding 25–30%, highlighting the company’s progress against strategic priorities and a buy rating with a 109 Hong Kong dollar target. BOCI maintained a buy rating, pointing to resilient second-quarter retail sales despite weak traffic and severe weather, and noted healthy inventory and stable discount levels; they flagged management changes as a normal organizational adjustment with limited operational impact. Goldman Sachs reiterated a buy rating with a 108 Hong Kong dollar target, emphasizing brand strength and the potential for share gains through disciplined execution and consistent product innovation. Citi placed the stock on a positive 30-day catalyst watch, expecting incremental share capture in the China market and supportive second-quarter retail read-throughs. Macquarie raised the target to 125 Hong Kong dollars, focusing on outdoor-led growth and premiumization tailwinds as contributors to continued margin resilience and improved mix. CICC sustained an outperform rating with a 110.91 Hong Kong dollar target, citing balanced growth, inventory health, and the strategic benefits of multi-brand operations. Nomura kept a buy rating at 89.90 Hong Kong dollars after adjusting the target, indicating confidence in execution while acknowledging broader sector pressure.</p>\n<p>These viewpoints align on several core themes relevant to this quarter’s print. First, they see a continuation of differentiated growth, where outdoor and premium brands lead expansion while ANTA and FILA maintain steady low-single-digit trends. Second, they expect margins to hold up, assuming discount levels remain contained and inventory stays healthy, a stance backed by recent operational updates. Third, they view leadership changes as manageable, with brand teams maintaining product cadence and retail execution without major disruption. Lastly, they anticipate that strategic mix upgrades and controlled promotions will underpin earnings durability into the remainder of the year. On balance, the consensus across these institutions indicates that the quarter is set up to meet or slightly exceed current expectations on profit quality, with the primary debate centered on the precise magnitude of top-line growth versus the degree of margin defense. With bullish commentary dominant among the named institutions, the market enters the result with a constructive bias predicated on confirming outdoor-led growth, stable discounting, and gross margin proximity to 60% in RMB terms.</p>\n","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Earning Preview: ANTA SPORTS this quarter’s revenue is expected to increase by 8%, and institutional views are bullish</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEarning Preview: ANTA SPORTS this quarter’s revenue is expected to increase by 8%, and institutional views are bullish\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1025659746\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/decf3d8a922fc5c1c1d787bf8b36173f);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Earnings Agent </p>\n<p class=\"h-time\">2026-08-19 10:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><h2>Abstract</h2>\nANTA Sports Products Limited will report results on August 26, 2026 post-Market, with investors watching revenue growth momentum, margin resilience, and brand-mix execution amid a competitive Chinese sportswear landscape.\n<h2>Market Forecast</h2>\nBased on recent operating disclosures and sell-side channel checks, this quarter’s revenue is projected to rise by about 8% year over year in RMB terms, supported by low-single-digit growth for the ANTA and FILA brands and faster expansion in higher-end outdoor labels; gross profit margin is expected to remain around the 60% area and net margin around the mid-teens, while adjusted EPS isn’t currently guided. The main business is expected to highlight balanced growth across core brands, steady pricing, and healthy inventory with a continued tilt toward premium performance and outdoor categories. The most promising segment appears to be the high-end “All Other Brands” cluster, with revenue of 17.00 billion RMB in the most recently reported period and a prior year growth rate of 59.20%, with recent retail indicators suggesting 25–30% year-over-year expansion for the quarter in focus.\n<h2>Last Quarter Review</h2>\nGross profit margin was 60.73%, net profit margin was 15.73%, and GAAP net profit attributable to shareholders was 3.28 billion RMB; revenue and adjusted EPS were not disclosed at the quarterly level. A key highlight was the stable margin profile alongside disciplined discounting and inventory control observed in recent trading updates. Main-business highlights: ANTA Brand generated 34.75 billion RMB, FILA produced 28.47 billion RMB, and All Other Brands delivered 17.00 billion RMB in the most recently reported period; meanwhile, recent operational updates indicated low-single-digit retail sales growth for ANTA and FILA and 25–30% growth for the outdoor-focused All Other Brands cohort.\n<h2>Current Quarter Outlook</h2>\n<h3>Main Business: Execution Discipline and Margin Resilience</h3>\nThe key focus for this quarter is on maintaining the quality of revenue in the core ANTA and FILA businesses. Recent retail trends point to low-single-digit growth for both brands, with management and sell-side tracking emphasizing stable discounting and healthier channel inventories. That backdrop, combined with a product mix anchored in performance running, basketball and athleisure, is conducive to sustaining gross margin near 60% even if top-line growth skews toward single digits. Operational execution remains central: the brand teams are leaning into tighter SKU management, targeted replenishment, and more granular retail operations to protect sell-through and minimize markdown risk. The company’s pricing and promotional cadence will be closely watched in the quarter given weather-related traffic variability and intense industry competition; nevertheless, recent commentary indicates the ability to hold pricing where product innovation is clearly communicated and hero franchises are supported by consistent marketing.</p>\n<p><h3>Most Promising Business: Outdoor and Premium Brands</h3>\nThe outdoor and premium brand cluster (reflected within “All Other Brands”) continues to be the fastest-growing part of the portfolio. In the most recently reported period, this group delivered 17.00 billion RMB of revenue, and the previous year’s growth rate of 59.20% underscores a robust base of demand and effective brand positioning; recent quarter retail indicators of 25–30% year-over-year growth suggest that momentum is carrying through into this quarter’s readout. The drivers behind this trajectory include rising consumer interest in outdoor and performance apparel, improvements in store productivity, and a broadened product range covering mountaineering, trail running, and urban outdoor crossovers. This mix typically carries structurally higher gross margins than mass-market lines, which can provide an incremental lift to group profitability when the outdoor share nudges higher. The market will watch whether supply-chain coordination and allocation planning can keep hot-selling items in stock while avoiding a build-up of slow movers, as this directly influences full-price sell-through and gross margin realization in the quarter.</p>\n<p><h3>What May Matter Most for the Stock: Growth-Mix, Discounts, and Retail Traffic</h3>\nThis quarter, share-price reaction is likely to be most sensitive to the interplay of growth-mix and discount discipline. If outdoor and premium labels again post high-20s growth and the company keeps promotional intensity contained across ANTA and FILA, investors may reward the print for margin stability even without outsized revenue acceleration. Conversely, any sign of a traffic-induced step-up in discounts or an inventory back-up would raise questions about the durability of margins into the second half. Another swing factor is the cadence of brand leadership transitions and how seamlessly those teams deliver product refresh cycles; early indications from sell-side checks suggest management changes have been orderly and effects on execution limited. Finally, the market will parse commentary on channel health and e-commerce momentum, looking for confirmation that sell-out is tracking ahead of sell-in and that online growth is offsetting any weather or traffic variability offline. In short, the path of least resistance for the stock this quarter is tied to confirming steady margins, validating the outdoor-led growth mix, and sustaining low-single-digit gains in ANTA and FILA without sacrificing price integrity.</p>\n<p><h2>Analyst Opinions</h2>\nThe prevailing institutional stance is bullish, with cited houses uniformly positive over the period reviewed. DBS Group Research analysts Alison Fok and Mavis Hui reiterated a constructive view as their channel work showed ANTA and FILA delivering low-single-digit retail growth with All Other Brands expanding 25–30%, highlighting the company’s progress against strategic priorities and a buy rating with a 109 Hong Kong dollar target. BOCI maintained a buy rating, pointing to resilient second-quarter retail sales despite weak traffic and severe weather, and noted healthy inventory and stable discount levels; they flagged management changes as a normal organizational adjustment with limited operational impact. Goldman Sachs reiterated a buy rating with a 108 Hong Kong dollar target, emphasizing brand strength and the potential for share gains through disciplined execution and consistent product innovation. Citi placed the stock on a positive 30-day catalyst watch, expecting incremental share capture in the China market and supportive second-quarter retail read-throughs. Macquarie raised the target to 125 Hong Kong dollars, focusing on outdoor-led growth and premiumization tailwinds as contributors to continued margin resilience and improved mix. CICC sustained an outperform rating with a 110.91 Hong Kong dollar target, citing balanced growth, inventory health, and the strategic benefits of multi-brand operations. Nomura kept a buy rating at 89.90 Hong Kong dollars after adjusting the target, indicating confidence in execution while acknowledging broader sector pressure.</p>\n<p>These viewpoints align on several core themes relevant to this quarter’s print. First, they see a continuation of differentiated growth, where outdoor and premium brands lead expansion while ANTA and FILA maintain steady low-single-digit trends. Second, they expect margins to hold up, assuming discount levels remain contained and inventory stays healthy, a stance backed by recent operational updates. Third, they view leadership changes as manageable, with brand teams maintaining product cadence and retail execution without major disruption. Lastly, they anticipate that strategic mix upgrades and controlled promotions will underpin earnings durability into the remainder of the year. On balance, the consensus across these institutions indicates that the quarter is set up to meet or slightly exceed current expectations on profit quality, with the primary debate centered on the precise magnitude of top-line growth versus the degree of margin defense. With bullish commentary dominant among the named institutions, the market enters the result with a constructive bias predicated on confirming outdoor-led growth, stable discounting, and gross margin proximity to 60% in RMB terms.</p>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02020":"安踏体育"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116654071","content_text":"Abstract\nANTA Sports Products Limited will report results on August 26, 2026 post-Market, with investors watching revenue growth momentum, margin resilience, and brand-mix execution amid a competitive Chinese sportswear landscape.\nMarket Forecast\nBased on recent operating disclosures and sell-side channel checks, this quarter’s revenue is projected to rise by about 8% year over year in RMB terms, supported by low-single-digit growth for the ANTA and FILA brands and faster expansion in higher-end outdoor labels; gross profit margin is expected to remain around the 60% area and net margin around the mid-teens, while adjusted EPS isn’t currently guided. The main business is expected to highlight balanced growth across core brands, steady pricing, and healthy inventory with a continued tilt toward premium performance and outdoor categories. The most promising segment appears to be the high-end “All Other Brands” cluster, with revenue of 17.00 billion RMB in the most recently reported period and a prior year growth rate of 59.20%, with recent retail indicators suggesting 25–30% year-over-year expansion for the quarter in focus.\nLast Quarter Review\nGross profit margin was 60.73%, net profit margin was 15.73%, and GAAP net profit attributable to shareholders was 3.28 billion RMB; revenue and adjusted EPS were not disclosed at the quarterly level. A key highlight was the stable margin profile alongside disciplined discounting and inventory control observed in recent trading updates. Main-business highlights: ANTA Brand generated 34.75 billion RMB, FILA produced 28.47 billion RMB, and All Other Brands delivered 17.00 billion RMB in the most recently reported period; meanwhile, recent operational updates indicated low-single-digit retail sales growth for ANTA and FILA and 25–30% growth for the outdoor-focused All Other Brands cohort.\nCurrent Quarter Outlook\nMain Business: Execution Discipline and Margin Resilience\nThe key focus for this quarter is on maintaining the quality of revenue in the core ANTA and FILA businesses. Recent retail trends point to low-single-digit growth for both brands, with management and sell-side tracking emphasizing stable discounting and healthier channel inventories. That backdrop, combined with a product mix anchored in performance running, basketball and athleisure, is conducive to sustaining gross margin near 60% even if top-line growth skews toward single digits. Operational execution remains central: the brand teams are leaning into tighter SKU management, targeted replenishment, and more granular retail operations to protect sell-through and minimize markdown risk. The company’s pricing and promotional cadence will be closely watched in the quarter given weather-related traffic variability and intense industry competition; nevertheless, recent commentary indicates the ability to hold pricing where product innovation is clearly communicated and hero franchises are supported by consistent marketing.\nMost Promising Business: Outdoor and Premium Brands\nThe outdoor and premium brand cluster (reflected within “All Other Brands”) continues to be the fastest-growing part of the portfolio. In the most recently reported period, this group delivered 17.00 billion RMB of revenue, and the previous year’s growth rate of 59.20% underscores a robust base of demand and effective brand positioning; recent quarter retail indicators of 25–30% year-over-year growth suggest that momentum is carrying through into this quarter’s readout. The drivers behind this trajectory include rising consumer interest in outdoor and performance apparel, improvements in store productivity, and a broadened product range covering mountaineering, trail running, and urban outdoor crossovers. This mix typically carries structurally higher gross margins than mass-market lines, which can provide an incremental lift to group profitability when the outdoor share nudges higher. The market will watch whether supply-chain coordination and allocation planning can keep hot-selling items in stock while avoiding a build-up of slow movers, as this directly influences full-price sell-through and gross margin realization in the quarter.\nWhat May Matter Most for the Stock: Growth-Mix, Discounts, and Retail Traffic\nThis quarter, share-price reaction is likely to be most sensitive to the interplay of growth-mix and discount discipline. If outdoor and premium labels again post high-20s growth and the company keeps promotional intensity contained across ANTA and FILA, investors may reward the print for margin stability even without outsized revenue acceleration. Conversely, any sign of a traffic-induced step-up in discounts or an inventory back-up would raise questions about the durability of margins into the second half. Another swing factor is the cadence of brand leadership transitions and how seamlessly those teams deliver product refresh cycles; early indications from sell-side checks suggest management changes have been orderly and effects on execution limited. Finally, the market will parse commentary on channel health and e-commerce momentum, looking for confirmation that sell-out is tracking ahead of sell-in and that online growth is offsetting any weather or traffic variability offline. In short, the path of least resistance for the stock this quarter is tied to confirming steady margins, validating the outdoor-led growth mix, and sustaining low-single-digit gains in ANTA and FILA without sacrificing price integrity.\nAnalyst Opinions\nThe prevailing institutional stance is bullish, with cited houses uniformly positive over the period reviewed. DBS Group Research analysts Alison Fok and Mavis Hui reiterated a constructive view as their channel work showed ANTA and FILA delivering low-single-digit retail growth with All Other Brands expanding 25–30%, highlighting the company’s progress against strategic priorities and a buy rating with a 109 Hong Kong dollar target. BOCI maintained a buy rating, pointing to resilient second-quarter retail sales despite weak traffic and severe weather, and noted healthy inventory and stable discount levels; they flagged management changes as a normal organizational adjustment with limited operational impact. Goldman Sachs reiterated a buy rating with a 108 Hong Kong dollar target, emphasizing brand strength and the potential for share gains through disciplined execution and consistent product innovation. Citi placed the stock on a positive 30-day catalyst watch, expecting incremental share capture in the China market and supportive second-quarter retail read-throughs. Macquarie raised the target to 125 Hong Kong dollars, focusing on outdoor-led growth and premiumization tailwinds as contributors to continued margin resilience and improved mix. CICC sustained an outperform rating with a 110.91 Hong Kong dollar target, citing balanced growth, inventory health, and the strategic benefits of multi-brand operations. Nomura kept a buy rating at 89.90 Hong Kong dollars after adjusting the target, indicating confidence in execution while acknowledging broader sector pressure.\nThese viewpoints align on several core themes relevant to this quarter’s print. First, they see a continuation of differentiated growth, where outdoor and premium brands lead expansion while ANTA and FILA maintain steady low-single-digit trends. Second, they expect margins to hold up, assuming discount levels remain contained and inventory stays healthy, a stance backed by recent operational updates. Third, they view leadership changes as manageable, with brand teams maintaining product cadence and retail execution without major disruption. Lastly, they anticipate that strategic mix upgrades and controlled promotions will underpin earnings durability into the remainder of the year. On balance, the consensus across these institutions indicates that the quarter is set up to meet or slightly exceed current expectations on profit quality, with the primary debate centered on the precise magnitude of top-line growth versus the degree of margin defense. With bullish commentary dominant among the named institutions, the market enters the result with a constructive bias predicated on confirming outdoor-led growth, stable discounting, and gross margin proximity to 60% in RMB terms.","news_type":1,"symbols_score_info":{"02020":1}},"isVote":1,"tweetType":1,"viewCount":784,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":574019581228112,"gmtCreate":1781149762626,"gmtModify":1781149767247,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4200118252877852","idStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/09988\">$BABA-W(09988)$&nbsp;</a> buying opportunity like this seleom presents itself. Buy buy buy!","listText":"<a href=\"https://ttm.financial/S/09988\">$BABA-W(09988)$&nbsp;</a> buying opportunity like this seleom presents itself. Buy buy buy!","text":"$BABA-W(09988)$ buying opportunity like this seleom presents itself. Buy buy buy!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/574019581228112","isVote":1,"tweetType":1,"viewCount":1805,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576326749731922","authorId":"3576326749731922","name":"Pablo_Chua","avatar":"https://community-static.tradeup.com/news/82ec063fd73ccbceee82eab015cdf3fd","crmLevel":12,"crmLevelSwitch":1,"authorIdStr":"3576326749731922","idStr":"3576326749731922"},"content":"$100 support level got to hold for it to rebound","text":"$100 support level got to hold for it to rebound","html":"$100 support level got to hold for it to rebound"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":596387255533944,"gmtCreate":1786629130774,"gmtModify":1786629133688,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4200118252877852","idStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/NKE\">$Nike(NKE)$ </a> bought at 40.63","listText":"<a href=\"https://ttm.financial/S/NKE\">$Nike(NKE)$ </a> bought at 40.63","text":"$Nike(NKE)$ bought at 40.63","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/596387255533944","isVote":1,"tweetType":1,"viewCount":1540,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"4200118252877852","idStr":"4200118252877852"},"content":"true. fortunately i exited within 2 days with tiny profit. I'm looking at ANTA.. entered earlier and it's in the money.","text":"true. fortunately i exited within 2 days with tiny profit. I'm looking at ANTA.. entered earlier and it's in the money.","html":"true. fortunately i exited within 2 days with tiny profit. I'm looking at ANTA.. entered earlier and it's in the money."},{"author":{"id":"4100255637029190","authorId":"4100255637029190","name":"VenVad","avatar":"https://static.itradeup.com/news/dfb6c2a9a5bd086a1a3f091f3e101e0b","crmLevel":11,"crmLevelSwitch":1,"authorIdStr":"4100255637029190","idStr":"4100255637029190"},"content":"Should have been invested in some other stock….","text":"Should have been invested in some other stock….","html":"Should have been invested in some other stock…."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":568774394848168,"gmtCreate":1779867147079,"gmtModify":1779867150375,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4200118252877852","idStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/COUR\">$Coursera, Inc.(COUR)$ </a> looking to re enter Cousera. I just logged in and try to take some swap derivatives course... It one of the the name external vendor. Unfortunately it's in Indian voice and i can't get used to the tone.. maybe Coursera would be better without such Indian providers.&nbsp;","listText":"<a href=\"https://ttm.financial/S/COUR\">$Coursera, Inc.(COUR)$ </a> looking to re enter Cousera. I just logged in and try to take some swap derivatives course... It one of the the name external vendor. Unfortunately it's in Indian voice and i can't get used to the tone.. maybe Coursera would be better without such Indian providers.&nbsp;","text":"$Coursera, Inc.(COUR)$ looking to re enter Cousera. I just logged in and try to take some swap derivatives course... It one of the the name external vendor. Unfortunately it's in Indian voice and i can't get used to the tone.. maybe Coursera would be better without such Indian providers.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/568774394848168","isVote":1,"tweetType":1,"viewCount":1256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":602898092167784,"gmtCreate":1788228899955,"gmtModify":1788253126926,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4200118252877852","idStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/ALB.HK 20260929 127.50 CALL\">$ALB.HK 20260929 127.50 CALL$ </a> I'm loading alot&nbsp; Afraid I might become sunstantial shareholder of Alibabar soon. Have to call Joe Tsai for coffee sometime to scold him.&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/ALB.HK 20260929 127.50 CALL\">$ALB.HK 20260929 127.50 CALL$ </a> I'm loading alot&nbsp; Afraid I might become sunstantial shareholder of Alibabar soon. Have to call Joe Tsai for coffee sometime to scold him.&nbsp;","text":"$ALB.HK 20260929 127.50 CALL$ I'm loading alot Afraid I might become sunstantial shareholder of Alibabar soon. Have to call Joe Tsai for coffee sometime to scold him.","images":[{"img":"https://community-static.tradeup.com/news/a3af66f88471eacb5bd1546850530f49","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/602898092167784","isVote":1,"tweetType":1,"viewCount":1623,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":577130377995280,"gmtCreate":1781925822185,"gmtModify":1781934327421,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4200118252877852","idStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/PONY\">$Pony AI Inc(PONY)$ </a> pony.ai provides driverless shuttle https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.straitstimes.com/singapore/transport/free-comfortdelgro-driverless-shuttle-rides-open-to-the-public-from-june-22&amp;ved=2ahUKEwix6eva7pSVAxW1aHADHXy1B38QFnoECCYQAQ&amp;usg=AOvVaw2YZBq3SqYS2D8mTPZFTiXf","listText":"<a href=\"https://ttm.financial/S/PONY\">$Pony AI Inc(PONY)$ </a> pony.ai provides driverless shuttle https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.straitstimes.com/singapore/transport/free-comfortdelgro-driverless-shuttle-rides-open-to-the-public-from-june-22&amp;ved=2ahUKEwix6eva7pSVAxW1aHADHXy1B38QFnoECCYQAQ&amp;usg=AOvVaw2YZBq3SqYS2D8mTPZFTiXf","text":"$Pony AI Inc(PONY)$ pony.ai provides driverless shuttle https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.straitstimes.com/singapore/transport/free-comfortdelgro-driverless-shuttle-rides-open-to-the-public-from-june-22&ved=2ahUKEwix6eva7pSVAxW1aHADHXy1B38QFnoECCYQAQ&usg=AOvVaw2YZBq3SqYS2D8mTPZFTiXf","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/577130377995280","isVote":1,"tweetType":1,"viewCount":1638,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":518920998585032,"gmtCreate":1767712614272,"gmtModify":1767713840135,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4200118252877852","idStr":"4200118252877852"},"themes":[],"title":"","htmlText":"Cute for Eczema!?","listText":"Cute for Eczema!?","text":"Cute for Eczema!?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/518920998585032","repostId":"2601892026","repostType":2,"repost":{"id":"2601892026","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1767704755,"share":"https://ttm.financial/m/news/2601892026?lang=en_US&edition=fundamental","pubTime":"2026-01-06 21:05","market":"us","language":"en","title":"Alumis Shares Surge 90% as Its Skin Disease Drug Meets Main Goal in Late-Stage Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2601892026","media":"Reuters","summary":"$Alumis(ALMS)$ said on Tuesday its experimental drug to treat a common skin disease met the main goal in two late-stage studies, offering hope for a new oral treatment option that affects millions of...","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/ALMS\">Alumis</a> said on Tuesday its experimental drug to treat a common skin disease met the main goal in two late-stage studies, offering hope for a new oral treatment option that affects millions of Americans.</p><p>Shares of the South San Francisco-based company soared about 90% in premarket trading.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/e52448eb1c0b1054f5ea8310f82ac423\" tg-width=\"837\" tg-height=\"615\"/></p><p>The drug, envudeucitinib, is being developed to treat moderate-to-severe plaque psoriasis, a chronic condition that causes red, scaly patches on the skin. Over 8 million people in the U.S. have psoriasis, according to the National Psoriasis Foundation.</p><p>In the trials, about 65% of patients saw their skin symptoms improve by 90% or more after 24 weeks of treatment. More than 40% of patients saw their symptoms clear up completely, the company said.</p><p>The drug also worked better than a placebo and outperformed Amgen&#39;s AMGN.O oral drug Otezla, Alumis added.</p><p>Leerink Partners analyst Thomas Smith said the drug offers &#34;potential for class-leading TYK2 inhibition&#34; and effectiveness approaching that of top-selling injectable drugs.</p><p>Envudeucitinib works by blocking TYK2, a protein that helps trigger immune signals linked to inflammation. This reduces the overactive immune response that causes psoriasis.</p><p>The company plans to seek U.S. regulatory approval for envudeucitinib in the second half of 2026. If cleared, it would compete with Bristol Myers Squibb&#39;s BMY.N Sotyktu, another drug in the same class approved for psoriasis in 2022.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alumis Shares Surge 90% as Its Skin Disease Drug Meets Main Goal in Late-Stage Trials</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlumis Shares Surge 90% as Its Skin Disease Drug Meets Main Goal in Late-Stage Trials\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-06 21:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><a href=\"https://laohu8.com/S/ALMS\">Alumis</a> said on Tuesday its experimental drug to treat a common skin disease met the main goal in two late-stage studies, offering hope for a new oral treatment option that affects millions of Americans.</p><p>Shares of the South San Francisco-based company soared about 90% in premarket trading.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/e52448eb1c0b1054f5ea8310f82ac423\" tg-width=\"837\" tg-height=\"615\"/></p><p>The drug, envudeucitinib, is being developed to treat moderate-to-severe plaque psoriasis, a chronic condition that causes red, scaly patches on the skin. Over 8 million people in the U.S. have psoriasis, according to the National Psoriasis Foundation.</p><p>In the trials, about 65% of patients saw their skin symptoms improve by 90% or more after 24 weeks of treatment. More than 40% of patients saw their symptoms clear up completely, the company said.</p><p>The drug also worked better than a placebo and outperformed Amgen&#39;s AMGN.O oral drug Otezla, Alumis added.</p><p>Leerink Partners analyst Thomas Smith said the drug offers &#34;potential for class-leading TYK2 inhibition&#34; and effectiveness approaching that of top-selling injectable drugs.</p><p>Envudeucitinib works by blocking TYK2, a protein that helps trigger immune signals linked to inflammation. This reduces the overactive immune response that causes psoriasis.</p><p>The company plans to seek U.S. regulatory approval for envudeucitinib in the second half of 2026. If cleared, it would compete with Bristol Myers Squibb&#39;s BMY.N Sotyktu, another drug in the same class approved for psoriasis in 2022.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU1670711123.USD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (USD) INC","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","LU1323610961.USD":"UBS (LUX) EQUITY SICAV - LONG TERM THEMES (USD) \"P\" (USD) ACC","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","BK4585":"ETF&股票定投概念","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU1868836757.USD":"CT (LUX) I AMERICAN FUND \"2\" (USD) ACC","LU1032466523.USD":"高盛全球多资产收益组合Acc","LU1670711040.USD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (USD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0306807586.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" (USD) INC QF","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU1261432733.SGD":"Fidelity World A-ACC-SGD","LU0122379950.USD":"贝莱德世界健康科学A2","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","BK4559":"巴菲特持仓","LU2125154935.USD":"ALLSPRING (LUX) WF GLOBAL EQUITY ENHANCED INCOME \"I\" (USD) INC","LU0058720904.USD":"联博国际健康护理基金A","ALMS":"Alumis Inc.","BK4588":"碎股","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU2242646821.SGD":"Fidelity Global Dividend Plus A-MINCOME(G)-SGD","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU1670710588.SGD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (SGD) ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","LU2242652126.USD":"FIDELITY FUNDS GLOBAL DIVIDENDS PLUS \"A\" (USD) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1670710661.SGD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (SGD) INC","BK4007":"制药","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC"},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL4N3Y70Q5:2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2601892026","content_text":"Alumis said on Tuesday its experimental drug to treat a common skin disease met the main goal in two late-stage studies, offering hope for a new oral treatment option that affects millions of Americans.Shares of the South San Francisco-based company soared about 90% in premarket trading.The drug, envudeucitinib, is being developed to treat moderate-to-severe plaque psoriasis, a chronic condition that causes red, scaly patches on the skin. Over 8 million people in the U.S. have psoriasis, according to the National Psoriasis Foundation.In the trials, about 65% of patients saw their skin symptoms improve by 90% or more after 24 weeks of treatment. More than 40% of patients saw their symptoms clear up completely, the company said.The drug also worked better than a placebo and outperformed Amgen's AMGN.O oral drug Otezla, Alumis added.Leerink Partners analyst Thomas Smith said the drug offers \"potential for class-leading TYK2 inhibition\" and effectiveness approaching that of top-selling injectable drugs.Envudeucitinib works by blocking TYK2, a protein that helps trigger immune signals linked to inflammation. This reduces the overactive immune response that causes psoriasis.The company plans to seek U.S. regulatory approval for envudeucitinib in the second half of 2026. If cleared, it would compete with Bristol Myers Squibb's BMY.N Sotyktu, another drug in the same class approved for psoriasis in 2022.","news_type":1,"symbols_score_info":{"ALMS":0.9}},"isVote":1,"tweetType":1,"viewCount":864,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":625760056766624,"gmtCreate":1793809404872,"gmtModify":1793811980899,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4200118252877852","idStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/TMDX 20261113 90.0 CALL\">$TMDX 20261113 90.0 CALL$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/TMDX 20261113 90.0 CALL\">$TMDX 20261113 90.0 CALL$ </a>&nbsp;","text":"$TMDX 20261113 90.0 CALL$","images":[{"img":"https://community-static.tradeup.com/news/d5a9cc701ad80ed5d5b510717c82de50","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/625760056766624","isVote":1,"tweetType":1,"viewCount":176,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":625760137560576,"gmtCreate":1793809331592,"gmtModify":1793809334432,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4200118252877852","idStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/OPT/INSP 20261120 60.0 PUT\">$INSP 20261120 60.0 PUT$ </a> sleep medicine&nbsp;","listText":"<a href=\"https://ttm.financial/OPT/INSP 20261120 60.0 PUT\">$INSP 20261120 60.0 PUT$ </a> sleep medicine&nbsp;","text":"$INSP 20261120 60.0 PUT$ sleep medicine","images":[{"img":"https://community-static.tradeup.com/news/7806c6d5d48db1a3fe4b1b734bc577cd","width":"894","height":"1391"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/625760137560576","isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":625745644085592,"gmtCreate":1793805862316,"gmtModify":1793805865307,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4200118252877852","idStr":"4200118252877852"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/OMH\">$Ohmyhome Ltd(OMH)$ </a> cannot open position today. Order denied. Only closing allowed. Why ah?","listText":"<a href=\"https://ttm.financial/S/OMH\">$Ohmyhome Ltd(OMH)$ </a> cannot open position today. Order denied. Only closing allowed. Why ah?","text":"$Ohmyhome Ltd(OMH)$ cannot open position today. Order denied. Only closing allowed. Why ah?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/625745644085592","isVote":1,"tweetType":1,"viewCount":168,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":562191625851920,"gmtCreate":1778285528964,"gmtModify":1778285532906,"author":{"id":"4200118252877852","authorId":"4200118252877852","name":"Fort Knox","avatar":"https://community-static.tradeup.com/news/8df3c5f3530d988b57d4c863e768a976","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4200118252877852","idStr":"4200118252877852"},"themes":[],"title":"","htmlText":"AMD has developed next generation tech for quantum computing. However it had remained unchartered territory for what is apparently a G level controlled tech. How is the company going to monetize it?","listText":"AMD has developed next generation tech for quantum computing. However it had remained unchartered territory for what is apparently a G level controlled tech. How is the company going to monetize it?","text":"AMD has developed next generation tech for quantum computing. However it had remained unchartered territory for what is apparently a G level controlled tech. How is the company going to monetize it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/562191625851920","isVote":1,"tweetType":1,"viewCount":1570,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}